Literature DB >> 11812088

Early-stage cervical adenocarcinoma treated by surgical intent: the role of para-aortic lymph node dissection.

Jayanthi S Lea1, Ellen E Sheets, Linda R Duska, David S Miller, John O Schorge.   

Abstract

OBJECTIVE: Previous reports suggest that cervical adenocarcinomas have a unique pattern of spread and are more apt to metastasize to para-aortic lymph nodes. The purpose of this study was to further define the node of para-aortic lymph node dissection in early-stage cervical adenocarcinoma treated by surgical intent.
METHODS: Institutional review board approval was obtained to perform a computerized search of the data of all women diagnosed with cervical adenocarcinoma between 1982 and 2000. Hospital charts were retrospectively reviewed. Follow-up was obtained from the tumor registry, medical records, and correspondence with health care providers.
RESULTS: Three hundred (87%) of 345 early-stage (FIGO IA(1)-IIA) cervical adenocarcinoma patients were primarily treated by surgical intent. Two hundred seventy-six underwent pelvic and para-aortic node dissection (n = 69) or pelvic node dissection only (n = 207); 24 had no lymph node dissection. The median number of lymph nodes removed was 13 pelvic (range, 1-58) and 3 para-aortic (range, 1-17). Three (4%) of 69 patients had para-aortic nodal metastases. Each had either grossly evident para-aortic adenopathy (n = 2) or an adnexal metastasis. Thirty-six of 40 women developing recurrent disease had at least some component of pelvic recurrence; 4 had only extrapelvic disease. Three patients undergoing para-aortic node dissection developed an isolated extrapelvic recurrence despite originally negative para-aortic nodes (n = 2) or treatment by extended-field radiation for para-aortic metastases. One woman undergoing only pelvic node dissection had an isolated extrapelvic recurrence despite originally negative nodes.
CONCLUSIONS: Early-stage cervical adenocarcinoma primarily treated by surgical intent has a very low risk of para-aortic metastases. These were detected only when there was gross evidence of nodal or adnexal disease. ©2002 Elsevier Science.

Entities:  

Mesh:

Year:  2002        PMID: 11812088     DOI: 10.1006/gyno.2001.6524

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  7 in total

Review 1.  Up-to-date management of lymph node metastasis and the role of tailored lymphadenectomy in cervical cancer.

Authors:  Noriaki Sakuragi
Journal:  Int J Clin Oncol       Date:  2007-06-27       Impact factor: 3.402

2.  Incidence of postoperative ileus after paraaortic lymph node dissection in patients with malignant gynecologic tumors.

Authors:  Kohei Fujita; Tadayoshi Nagano; Akira Suzuki; Atsuko Sakakibara; Syugen Takahashi; Takeshi Hirano; Atsuhiko Okagaki; Chiaki Ban
Journal:  Int J Clin Oncol       Date:  2005-06       Impact factor: 3.402

3.  The EANM clinical and technical guidelines for lymphoscintigraphy and sentinel node localization in gynaecological cancers.

Authors:  Francesco Giammarile; M Fani Bozkurt; David Cibula; Jaume Pahisa; Wim J Oyen; Pilar Paredes; Renato Valdes Olmos; Sergi Vidal Sicart
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-03-08       Impact factor: 9.236

Review 4.  Adenocarcinoma of the cervix.

Authors:  John O Schorge; Lynne M Knowles; Jayanthi S Lea
Journal:  Curr Treat Options Oncol       Date:  2004-04

5.  Intra-operative frozen section analysis of common iliac lymph nodes in patients with stage IB1 and IIA1 cervical cancer.

Authors:  Xiaojuan Lv; Lu Chen; Hua Yu; Xiang Zhang; Dingding Yan
Journal:  Arch Gynecol Obstet       Date:  2011-08-12       Impact factor: 2.344

6.  How important is the number of pelvic lymph node retrieved to locorregional staging of cervix cancer?

Authors:  Thales Paulo Batista; Artur Lício Rocha Bezerra; Mário Rino Martins; Vandré Cabral Gomes Carneiro
Journal:  Einstein (Sao Paulo)       Date:  2013-12

Review 7.  The sentinel node approach in gynaecological malignancies.

Authors:  Angela Collarino; Sergi Vidal-Sicart; Germano Perotti; Renato A Valdés Olmos
Journal:  Clin Transl Imaging       Date:  2016-06-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.